Showing 1271-1280 of 9076 results for "".
Basal Cell Carcinoma in Skin of Color: Diagnosis and Treatment Considerations
https://practicaldermatology.com/topics/general-topics/basal-cell-carcinoma-in-skin-of-color-diagnosis-and-treatment-considerations/21177/BCC may be less common in more darkly pigmented skin, but it occurs, and diagnosis may be delayed. Appropriate treatment is crucial.Update on Human Safety and the Environmental Impact of Physical and Chemical Sunscreen Filters
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-human-safety-and-the-environmental-impact-of-physical-and-chemical-sunscreen-filters/20800/What do we know about the effects of these commonly used and important molecules?Alternative Therapies for the Treatment of Acne
https://practicaldermatology.com/topics/acne-rosacea/alternative-therapies-for-the-treatment-of-acne/23787/Many patients are interested in alternative options instead of or alongside prescription acne treatments.Topical Treatments for Hidradenitis Suppurativa
https://practicaldermatology.com/topics/rare-disease/topical-treatments-for-hidradenitis-suppurativa/56433/Topical therapies can provide benefit by reducing bacterial burden, decreasing inflammation, and providing symptomatic relief from minor localized flares.Total Body Skin Exams: Don't Abandon Them
https://practicaldermatology.com/topics/skin-cancer-photoprotection/total-body-skin-exams-dont-abandon-them/20628/Lesion-directed exams may save time, but is the limited temporal savings worth it?Pipeline and Potential Roles for GLP-1RAs in Dermatology
https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/Having reviewed the mechanism of action and current roles in medicine for glucagon-like peptide 1 receptor agonists (GLP-1RAs), we now can discuss therapies in this class currently under investigation for management of dermatologic disease.Comorbidities in Alopecia Areata
https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/Alopecia areata (AA) is a chronic, relapsing immune-mediated disorder that causes nonscarring hair loss that can significantly impact a patient’s quality of life.Setting Things Right
https://practicaldermatology.com/issues/supplements/setting-things-right/23412/Understanding the Role of Balneotherapy in Treating Moderate to Severe Atopic Dermatitis"Psleep": Psoriasis and Sleep
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/psleep-psoriasis-and-sleep/29075/The “invisible” impacts of psoriasis are those not directly seen on examination. These include itch, pain, fatigue and sleep dysfunction, which may be improved by our systemic therapies. However, there is a gap between the patients’ reporting of these experienced invisible impacts and their physiciaBarrier Repair: Where Do We Stand?
https://practicaldermatology.com/topics/general-topics/barrier-repair-where-do-we-stand/21455/An update on skin moisturization and the use of prescription barrier repair agents for atopic dermatitis.